ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "2: Everything You Need to Know from the American College of Cardiology 2025 Scientific Session"
Episode Synopsis
This episode discussed multiple studies. See the list below for links to articles and relevant content:
REVERSE-IT trial data:
https://www.pharmacytimes.com/view/acc-2025-ticagrelor-antidote-restores-platelet-function-treats-bleeding
https://evidence.nejm.org/doi/full/10.1056/EVIDoa210004
FAIR-HF2 trial data:
https://www.pharmacytimes.com/view/acc-2025-intravenous-iron-safe-but-results-in-mixed-findings-for-patients-with-heart-failure
https://jamanetwork.com/journals/jama/fullarticle/2832132
STRIDE trial data:
https://www.pharmacytimes.com/view/acc-2025-semaglutide-significantly-improves-walking-distance-symptoms-qol-for-individuals-with-pad-and-diabetes
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00509-4/abstract
ADVANCE-HTN trial: https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2025/03/27/15/49/advance-htn
FRESH-UP trial: https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2025/03/27/17/26/fresh-up
FINEARTS-HF trial: https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2025/03/05/17/27/FINEARTS-HF-Analysis
In God we trust